Ultralife Corporation Reports Q2 Growth in Revenue but Profitability Declines Amid Rising Costs

Ultralife Corporation (NASDAQ: ULBI) has reported its Q2 financial results which reveal both positive and negative aspects:

Key Financial Highlights:

• Revenue: Q2 2025 revenues increased to $48.6 million, up 13.0% from $43.0 million in Q2 2024.
• Net Income: Net income attributable to Ultralife was $0.88 million ($0.05 per share) compared to $2.97 million ($0.18 per share) in Q2 2024, indicating a significant decline.
• Gross Profit Margin: Margins fell to 23.9% from 26.9%, largely due to higher costs and unfavorable product mix.
• Operating Income: Decreased to $2.26 million (4.6% of revenues) from $3.92 million (9.1% of revenues), primarily driven by increased operational expenses.
• Operating Expenses: Increased by 22.2% to $9.35 million due to the inclusion of Electrochem's figures and higher new product development costs.
• Debt: As of June 30, 2025, Ultralife had $51.6 million outstanding on its Term Loan with no amounts on the Revolving Credit Facility, demonstrating compliance with debt covenants.
• Cash Position: Cash on hand is $10.9 million, a notable rise from $6.85 million at year-end 2024.

Positive Aspects of the Income Statement:

• Growth in revenue from the Battery & Energy Products segment, which reflected strong demand, particularly from government/defense customers.
• Income tax provisions reflect effective management of tax liabilities, leveraging net operating loss carryforwards effectively.
• Operational cash flow improved to $9.3 million, up from $8.8 million year-over-year.

Negative Aspects of the Income Statement:

• Significant decrease in net income with a sharp drop in earnings per share (EPS).
• Higher operational costs led to a diminishing operating income and reduced gross margins.
• Communications Systems segment revenue dramatically decreased by 57.2%, significantly impacting overall profitability.

In summary, while Ultralife Corporation has experienced growth in revenue, primarily due to increased defense spending, its profitability has been hampered by increased costs and margin pressures. The acquisition of Electrochem is seen as a double-edged sword, providing growth prospects but also contributing to immediate operational challenges.